Tatiana Borodina

Head of sequencing at Alacris Theranostics since 2012.

Dr. Borodina has over 10 years of experience in molecular biology and has worked in the field of NGS since 2007. She has been involved in numerous small- and large-scale NGS projects and is co-author of a number of patents for NGS technology, including dUTP based strain specific RNASeq, which has been licensed by NEB and Illumina.

Partners

Logo1 Alacris
Logo2 Lab Analtica
Iit Logo
Logo4 Udeparis
Logo3 Ubarcelona

flag yellow lowThis project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 687089